Logo Image
News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesShortsSpecial ReportVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement
|Articles|August 3, 2011

Contraception - Lactational Amenorrhea Method

Author(s)M. Nabil El-Tabbakh, MD
Advertisement
Advertisement
Contraception

Related Content

Advertisement
Previewing women's health regulatory updates and conferences in the 2nd half of 2026 | Image credit: Stock.adobe.com

Previewing women's health regulatory updates and conferences in the 2nd half of 2026

ByContemporary OB/GYN Staff
June 26th 2026
FDA: Levonorgestrel/ethinyl estradiol birth control patch sees update to labeled strength

FDA: Levonorgestrel/ethinyl estradiol birth control patch sees update to labeled strength

ByJoshua Fitch, Senior Editor
June 19th 2026
The top headlines in women's health from May 2026

The top headlines in women's health from May 2026

ByJoshua Fitch, Senior Editor
May 29th 2026
Mifepristone via telehealth, mail order can continue amid lawsuit, Supreme Court says | | Image credit: © SolsticeStudio - stock.adobe.com

Mifepristone via telehealth, mail order can continue amid lawsuit, Supreme Court says

ByJoshua Fitch, Senior Editor
May 15th 2026
Ovaprene phase 3 interim data supports potential of monthly hormone-free contraceptive | Image credit: Stock.Adobe.com

Ovaprene phase 3 interim data supports potential of monthly hormone-free contraceptive

ByJoshua Fitch, Senior Editor
Published: May 13th 2026 | Updated: June 17th 2026

Latest CME

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women
Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

View more
Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

SWAN analysis: Sleep, not VMS alone, drives quality-of-life decline in menopause

2

Previewing women's health regulatory updates and conferences in the 2nd half of 2026

3

How is elinzanetant impacting sleep in postmenopausal women?

4

FAQ: What you need to know about ACOG's new maternal immunization schedule

5

Cesarean scar ectopic pregnancy: Management updates and challenges in a post-Roe era

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us